Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALT COVID-19
NCT04381364Phase 2Unknown
- Start
- May 2020
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ciclesonide in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
ciclesonide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04381364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04381364.